FDA Inspection 1107590 — Aspire Fertility Institute San Antonio
The FDA completed an inspection of Aspire Fertility Institute San Antonio on Oct 3, 2019 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 3, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Antonio, TX (United States)